Eteplirsen
ATC M09AX06 · 3 markets · 7 records
US 4 records · 3 strengths
- 500 mg/10 mLinjectionManufacturer: Catalent Indiana, LLC ×2
- 100 mg/2 mLinjectionManufacturer: Catalent Indiana, LLC ×2
- 50 mginjectionExondys 51
GB 2 records · 2 strengths
- 500 mg/10 mLinjectionExondys 51 100mg/2ml solution for injection vials
- 100 mg/2 mLinjectionExondys 51 100mg/2ml solution for injection vials
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Exondys
| Strength / form / release | US | GB | EU |
|---|---|---|---|
| 500 mg/10 mL injection | Manufacturer: Catalent Indiana, LLC ×2 | Exondys 51 100mg/2ml solution for injection vials | |
| 100 mg/2 mL injection | Manufacturer: Catalent Indiana, LLC ×2 | Exondys 51 100mg/2ml solution for injection vials | |
| 50 mg injection | Exondys 51 | ||
unknown | Exondys |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.